{"nctId":"NCT01096017","briefTitle":"To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study","startDateStruct":{"date":"2010-03"},"conditions":["Asthma"],"count":24,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: Terbutaline Turbuhaler®","Other: pMDI placebo pMDI","Other: Placebo Turbuhaler®"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: Salbutamol pMDI","Other: pMDI placebo pMDI","Other: Placebo Turbuhaler®"]}],"interventions":[{"name":"Terbutaline Turbuhaler®","otherNames":["Bricanyl Turbuhaler"]},{"name":"Salbutamol pMDI","otherNames":["Saltanol"]},{"name":"pMDI placebo pMDI","otherNames":[]},{"name":"Placebo Turbuhaler®","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* On ICS for at least 3 months from Visit 2 and with a prescribed constant dose during the 4 weeks prior to Visit 2\n* Forced Expiratory Volume in 1 Second (FEV1) of at least 50 % of predicted normal value pre-bronchodilator\n* Reversible airway obstruction according to reversibility test performed at Visit 2, defined as an increase in Forced Expiratory Volume in 1 Second (FEV1) ≥12% relative baseline at 15-30 minutes after inhalation of in total 400 μg salbutamol\n\nExclusion Criteria:\n\n* Treatment with oral, parenteral or rectal GCS (Glucocorticosteroids)within 4 weeks or depot parenteral GCS (Glucocorticosteroids) within 3 months prior to Visit 2.\n* Change in prescribed asthma medication due to exacerbation of asthma within 4 weeks prior to Visit 2 or being hospitalized due to exacerbation of asthma within 8 weeks prior to Visit 2.","healthyVolunteers":false,"sex":"ALL","minimumAge":"16 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"FEV1 (Forced Expiratory Volume in 1 Second) Area Under Curve (AUC) 0-4 Hours After Drug Inhalation","description":"FEV1 (Forced Expiratory Volume in 1 second) AUC 0-4 hours after drug inhalation","paramType":"GEOMETRIC_MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"617.56","spread":null},{"groupId":"OG001","value":"634.64","spread":null}]}]}]},{"type":"SECONDARY","title":"FEV1 (Forced Expiratory Volume in 1 Second) at 5 Minutes After Inhalations of Study Drug as Percentage of Pre-dose","description":"percent of pre-dose (ratio)","paramType":"GEOMETRIC_MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"115.58","spread":null},{"groupId":"OG001","value":"112.80","spread":null}]}]}]},{"type":"SECONDARY","title":"FEV1 (Forced Expiratory Volume in 1 Second) at 15 Minutes After Inhalations of Study Drug as Percentage of Pre-dose","description":"percent of pre-dose (ratio)","paramType":"GEOMETRIC_MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"118.15","spread":null},{"groupId":"OG001","value":"115.69","spread":null}]}]}]},{"type":"SECONDARY","title":"FEV1 (Forced Expiratory Volume in 1 Second) at 30 Minutes After Inhalations of Study Drug as Percentage of Pre-dose","description":"percent of pre-dose (ratio)","paramType":"GEOMETRIC_MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"119.42","spread":null},{"groupId":"OG001","value":"117.02","spread":null}]}]}]},{"type":"SECONDARY","title":"FEV1 (Forced Expiratory Volume in 1 Second) at 60 Minutes After Inhalations of Study Drug as Percentage of Pre-dose","description":"percent of pre-dose (ratio)","paramType":"GEOMETRIC_MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"120.28","spread":null},{"groupId":"OG001","value":"118.11","spread":null}]}]}]},{"type":"SECONDARY","title":"FEV1 (Forced Expiratory Volume in 1 Second) at 120 Minutes After Inhalations of Study Drug as Percentage of Pre-dose","description":"percent of pre-dose (ratio)","paramType":"GEOMETRIC_MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"119.54","spread":null},{"groupId":"OG001","value":"119.79","spread":null}]}]}]},{"type":"SECONDARY","title":"FEV1 (Forced Expiratory Volume in 1 Second) at 180 Minutes After Inhalations of Study Drug as Percentage of Pre-dose","description":"percent of pre-dose (ratio)","paramType":"GEOMETRIC_MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"116.68","spread":null},{"groupId":"OG001","value":"118.48","spread":null}]}]}]},{"type":"SECONDARY","title":"FEV1 (Forced Expiratory Volume in 1 Second) at 240 Minutes After Inhalations of Study Drug as Percentage of Pre-dose","description":"percent of pre-dose (ratio)","paramType":"GEOMETRIC_MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"113.59","spread":null},{"groupId":"OG001","value":"117.05","spread":null}]}]}]},{"type":"SECONDARY","title":"Maximum % Change in FEV1 (Forced Expiratory Volume in 1 Second) Within 4 Hours After Drug Inhalation","description":"percent of pre-dose (ratio)","paramType":"GEOMETRIC_MEAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"122.62","spread":null},{"groupId":"OG001","value":"121.43","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Peak FEV1 (Forced Expiratory Volume in 1 Second) Within 4 Hours After Drug Inhalation","description":"Time to peak measurement of FEV1 (min)","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60.00","spread":null},{"groupId":"OG001","value":"120.00","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Patients With % Change in FEV1 (Forced Expiratory Volume in 1 Second) >15% Within 4 Hours After Drug Inhalation","description":"Number of patients with % change in FEV1 \\>15% within 4 hours after drug inhalation.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]}]},{"type":"SECONDARY","title":"Time to Change More Than or Equal to 15% (Time to Onset Response) Within 4 Hours After Drug Inhalation","description":"Time to change more than or equal to 15% (time to onset response) within 4 hours after drug inhalation","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31.36","spread":"37.49"},{"groupId":"OG001","value":"34.32","spread":"40.31"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":23},"commonTop":[]}}}